SCHEMBL5314643

SCHEMBL5314643

CCCON=C(COc1cc2ccccc2cc1C(=O)OC)c1cc(-c2ccc(F)cc2)no1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ RXFP1 Q9HBX9 1/20 0.42
▸ MAPT P10636 4/20 0.40
▸ PPARG P37231 2/20 0.38
▸ PPARA Q07869 2/20 0.38
▸ PTPN1 P18031 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ TP53 P04637 1/20 0.37
▸ NPC1 O15118 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ SLC6A4 P31645 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP8 Q96LD8 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5314640 1.00 PLA2G2A (0.42) PLA2G2ASMN1; SMN2RAB9AKDM4EMEN1
SCHEMBL5310846 0.92 PDE10A (0.43) SMN1; SMN2RAB9AKDM4EMEN1KMT2A
SCHEMBL14530972 0.92 PDE10A (0.43) SMN1; SMN2RAB9AKDM4EMEN1KMT2A
SCHEMBL5312222 0.88 PLA2G2A (0.42) PLA2G2ASMN1; SMN2RAB9AKDM4EMEN1
SCHEMBL5312224 0.88 PLA2G2A (0.42) PLA2G2ASMN1; SMN2RAB9AKDM4EMEN1
SCHEMBL5342145 0.86 MAPT (0.43) PLA2G2ASMN1; SMN2RAB9AKDM4EMEN1
SCHEMBL5342152 0.86 MAPT (0.43) PLA2G2ASMN1; SMN2RAB9AKDM4EMEN1
SCHEMBL5315798 0.85 MAPT (0.39) PLA2G2ASMN1; SMN2RAB9AKDM4EMEN1
SCHEMBL5315795 0.85 MAPT (0.39) PLA2G2ASMN1; SMN2RAB9AKDM4EMEN1
SCHEMBL5314031 0.85 MEN1 (0.41) SMN1; SMN2RAB9AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007058504-A1 NOVEL COMPOUNDS AS AGONIST FOR PPAR GAMMA AND PPAR ALPHA, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME LG LIFE SCIENCES, LTD. (KR) 2007-05-24 — — WO disclosed
Send feedback